Multidrug resistance-associated proteins and implications in drug development

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 1, 2010, Pages 115-120

  Liu, Ya He ^a   Di, Yuan Ming ^a   Zhou, Zhi Wei ^a   Mo, Sui Lin ^a   Zhou, Shu Feng ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Drug development; Drug transport; Multidrug resistance associated proteins; Pharmacokinetics; Toxicity

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTIANDROGEN; BERBERINE; BILE ACID; BILIRUBIN GLUCURONIDE; CIPROFLOXACIN; COLCHICINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DACTINOMYCIN; DIFLOXACIN; EPIPODOPHYLLOTOXIN; EPOTHILONE DERIVATIVE; GLUCURONIC ACID; GLUTATHIONE; GREPAFLOXACIN; INDINAVIR; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 6; PIRARUBICIN; RITONAVIR; SAQUINAVIR; TAXANE DERIVATIVE; UNINDEXED DRUG; VINCA ALKALOID;

BINDING AFFINITY; CONFERENCE PAPER; DRUG DEVELOPMENT; DRUG DISPOSITION; DRUG EXCRETION; ENZYME SPECIFICITY; HUMAN; NUCLEOTIDE TRANSPORT; PROTEIN BINDING; PROTEIN LOCALIZATION; PSEUDOXANTHOMA ELASTICUM; TUMOR RESISTANCE;

ANTINEOPLASTIC AGENTS; DRUG DISCOVERY; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION;

EID: 73649120349     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05252.x     Document Type: Conference Paper

References (38)

1. Stanley LA, Horsburgh BC, Ross J, Scheer N, Wolf CR. Drug transporters: Gatekeepers controlling access of xenobiotics to the cellular interior. Drug Metab. Rev. 2009 41 : 27 65.
2. Toyoda Y, Hagiya Y, Adachi T, Hoshijima K, Kuo MT, Ishikawa T. MRP class of human ATP binding cassette (ABC) transporters: Historical background and new research directions. Xenobiotica 2008 38 : 833 862.
3. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 2002 71 : 537 592.
4. Zhou SF, Wang LL, Di YM et al. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr. Med. Chem. 2008 15 : 1981 2039.
5. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, Cole SP. Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J. Biol. Chem. 2001 276 : 27846 27854.
6. Hammond CL, Marchan R, Krance SM, Ballatori N. Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J. Biol. Chem. 2007 282 : 14337 14347.
7. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 1996 56 : 988 994. (Pubitemid 26065391)
8. Cole SP, Sparks KE, Fraser K et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 1994 54 : 5902 5910.
9. Leslie EM, Haimeur A, Waalkes MP. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J. Biol. Chem. 2004 279 : 32700 32708.
10. Hooijberg JH, Broxterman HJ, Kool M et al. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 1999 59 : 2532 2535.
11. Kool M, van der Linden M, de Haas M et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl Acad. Sci. USA 1999 96 : 6914 6919.
12. Russel FG, Koenderink JB, Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): A versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol. Sci. 2008 29 : 200 207.
13. Chen ZS, Lee K, Walther S et al. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 2002 62 : 3144 3150.
14. Schuetz JD, Connelly MC, Sun DX et al. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med. 1999 5 : 1048 1051.
15. Rius M, Thon WF, Keppler D, Nies AT. Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. J. Urol. 2005 174 : 2409 2414.
16. Chen ZS, Lee K, Kruh GD. Transport of cyclic nucleotides and estradiol 17-β-d-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem. 2001 276 : 33747 33754.
17. Wijnholds J, deLange EC, Scheffer GL et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 2000 105 : 279 285.
18. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 2002 62 : 6172 6177.
19. Chen ZS, Hopper-Borge E, Belinsky MG, Shchaveleva I, Kotova E, Kruh GD. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol. Pharmacol. 2003 63 : 351 358.
20. Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG, Kruh GD. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): Resistance to docetaxel. Cancer Res. 2004 64 : 4927 4930.
21. Kruh GD, Guo Y, Hopper-Borge E, Belinsky MG, Chen ZS. ABCC10, ABCC11, and ABCC12. Pflügers Arch. 2007 453 : 675 684.
22. Oguri T, Bessho Y, Achiwa H et al. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol. Cancer Ther. 2007 6 : 122 127.
23. Guo Y, Kotova E, Chen ZS et al. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl) adenine. J. Biol. Chem. 2003 278 : 29509 29514.
24. Bera TK, Iavarone C, Kumar V, Lee S, Lee B, Pastan I. MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc. Natl Acad. Sci. USA 2002 99 : 6997 7002.
25. Bakos E, Evers R, Sinko E, Varadi A, Borst P, Sarkadi B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol. 2000 57 : 760 768.
26. 125I]LY475776. Evidence of a major binding site in the COOH-proximal membrane spanning domain. J. Biol. Chem. 2002 277 : 28690 28699.
27. Chan LM, Lowes S, Hirst BH. The ABCs of drug transport in intestine and liver: Efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 2004 21 : 25 51.
28. Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008 38 : 802 832.
29. Yu XQ, Xue CC, Wang G, Zhou SF. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. Curr. Drug Metab. 2007 8 : 787 802.
30. Noguchi K, Katayama K, Mitsuhashi J, Sugimoto Y. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv. Drug Deliv. Rev. 2009 61 : 26 33.
31. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 1976 455 : 152 162.
32. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer. Role of ATP-dependent transporters. Nat. Rev. Cancer 2002 2 : 48 58.
33. Zhou SF. Role of multidrug resistance associated proteins in drug development. Drug Discov. Ther. 2008 2 : 305 332.
34. Leitner HM, Kachadourian R, Day BJ. Harnessing drug resistance: Using ABC transporter proteins to target cancer cells. Biochem. Pharmacol. 2007 74 : 1677 1685.
35. Sauna ZE, Nandigama K, Ambudkar SV. Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: Effect of transport substrates and characterization of the post-hydrolysis transition state. J. Biol. Chem. 2004 279 : 48855 48864.
36. Lee JJ, Kelly WK. Epothilones: Tubulin polymerization as a novel target for prostate cancer therapy. Nat. Clin. Pract. Oncol. 2009 6 : 85 92.
37. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006 5 : 219 234.
38. Perego P, De Cesare M, De Isabella P et al. A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Cancer Res. 2001 61 : 6034 6037.